In this issue:
Promotion of anti-tumour immunity from exercise induces engagement of IL-15Rα axis
Niraparib + nivolumab or niraparib + ipilimumab for platinum-sensitive advanced pancreatic cancer
Nivolumab + ipilimumab combined with SBRT
Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1
Neoadjuvant therapy alters immune microenvironment in pancreatic cancer
Efficacy and safety of gemcitabine + nab-paclitaxel vs. gemcitabine alone in older adults
Short- and long-term outcomes of pancreatic cancer resection in elderly patients
Gallstones and risk of cancers of the liver, biliary tract and pancreas
Prognostic significance of peritoneal lavage cytology in gastric cancer in Singapore
Patterns of disease relapse and post-treatment follow-up of patients with resected pancreatic adenocarcinoma
Please login below to download this issue (PDF)